Johnson & Johnson is engaged in a dozen fields including medicine, health care, medical diagnostics, medical devices and personal care products, consumer goods and so on. In the Chinese market, its brands include Tylenol, Bondi, Merrill Lynch, Zyrtec, Risperdal, domperidone, Miconazole, Triatop, Neutrogena, Clean & Clear, Listerine mouthwash and dozens of well-known brands. In 2012, Johnson & Johnson was ranked as No. 138 of the world’s top 500 with operating revenue of US $65 billion.
From April 2005 to May 2013, Johnson & Johnson had initiated at least 51 times recall involving its 13 subsidiaries and 27 kinds of drugs. These products were mostly sold in mainland of China when the recalls were announced. But for 48 times, recalls or investigations were not organized in the Chinese market. When the media questioned Johnson & Johnson in term of implementing “double standards” in China, the Johnson & Johnson gave majorly two answers:
- The batches of products to be recalled are not sold in China;
- All products made in China meet the standards of China.